Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Incline Peps currently separates Retatrutide options into core Reta, pen-format Reta products and x10 vial supply
1 REIMAGINE 2 was a 68-week phase 3 trial evaluating the safety and efficacy of CagriSema in doses 2.4 mg/2.4 mg and 1 mg/1 mg once weekly versus semaglutide 2.4 mg, semaglutide 1 mg, cagrilintide 2.4 mg, and dose-matched placebo in 2,713 adults with T2D inadequately controlled with metformin with or without an SGLT2 inhibitor
However, retatrutide remains an investigational medicinal product and, as of mid-2025, has not been approved for clinical use in the United Kingdom or elsewhere
En este contexto, la Unidad Endocrinologa de Pharmatech ha incorporado recientemente STARELLE (semaglutida) a su portafolio, ampliando las alternativas disponibles para el manejo clnico de la diabetes tipo 2 y el control de la obesidad
Eligibility and clinical criteria Weight loss GLP-1 drugs are subject to clinical criteria for prescribing, for example, meeting a certain body mass index (BMI)
